Discontinuation report ACT ROSUVASTATIN

Last updated on 2018-10-22 History
Report ID 65322
Drug Identification Number 02339773
Brand name ACT ROSUVASTATIN
Common or Proper name ROSUVASTATIN
Company Name ACTAVIS PHARMA COMPANY
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-07-31
Remaining supply date 2018-07-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Transitioned. TEVA available
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-10-22 French Compare
v1 2018-10-22 English Compare